Malaria drug could combat chemotherapy-resistant head and neck cancers, research suggests
Published Date: 3/14/2022
Source: sciencedaily.com
A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumor-killing effects of cisplatin in animal models.
